Industry News

AAA Receives Orphan Drug Designation from FDA and EMA for Gallium-68 DOTATATE for Use in Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors
FDA Grants 'Orphan Drug' Designation for Genervon's Breakthrough Multi-Target ALS Bio-Drug GM604
U.S. FDA approves Bydureon Pen (exenatide extended-release for injectable suspension) for Once-Weekly Treatment of Adults with Type 2 Diabetes
Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Two Lots of Zoledronic Acid Injection, 5mg/100mL due to Potential Lack of Container Integrity
FDA Grants �Orphan Drug� Designation for Genervon�s Breakthrough Multi-Target ALS Bio-Drug GM604
U.S. FDA Approves Bydureon� Pen (exenatide extended-release for injectable suspension) for Once-Weekly Treatment of Adults with Type 2 Diabetes
SafeOp Surgical Gets FDA Clearance for EPAD Neuromonitoring Device
Bayer to acquire Dihon Pharmaceutical Group Co., Ltd. in China; Transaction strengthens Consumer Care business and moves Bayer HealthCare to a leading OTC position in key growth country
FDA Grants �Orphan Drug� Designation for Genervon�s Breakthrough Multi-Target ALS Bio-Drug GM604
SafeOp Surgical Gets FDA Clearance for EPAD Neuromonitoring Device
House Energy and Commerce Subcommittee on Oversight and Investigations Hearing "Counterfeit Drugs: Fighting Illegal Supply Chains."Testimony by John Clark, Vice President and Chief Security Officer, Global Security, Compliance Division, Pfizer
FDA urged to reconsider new drug Zohydro
House Energy and Commerce Subcommittee on Oversight and Investigations Hearing "Counterfeit Drugs: Fighting Illegal Supply Chains."Testimony by John Clark, Vice President and Chief Security Officer, Global Security, Compliance Division, Pfizer
U.Md. program awards $4.1 million to companies and faculty developing tech products
Public Citizen Petitions FDA for a Black Box Warning on Testosterone Products
U.Md. program awards $4.1 million to companies and faculty developing tech products
FDA clears Bristol drug for rare fat disorder
Pfizer pleased with pneumonia vaccine trial for older adults
BioCryst Announces Peramivir NDA Acceptance by the FDA
Public Citizen Petitions FDA for a Black Box Warning on Testosterone Products
FDA urged to reconsider new drug Zohydro
Pfizer Announces FDA Approval to Include Radiographic Data on Reduction of Progression of Structural Joint Damage for Adults with Moderately to Severely Active Rheumatoid Arthritis in Labeling for XELJANZ� (tofacitinib citrate)
Medline Selected as Exclusive Provider of Custom Procedure Trays for Upper Midwest Consolidated Services Center
Bristol-Myers Squibb Receives U.S. FDA Breakthrough Therapy Designation for All-Oral Daclatasvir Dual Investigational Regimen for Chronic Hepatitis C
Pharma Regulatory Affairs Groups Are Placing Greater Importance on Regulatory Intelligence